BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33855861)

  • 1. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Bryant KB; Moran AE; Kazi DS; Zhang Y; Penko J; Ruiz-Negrón N; Coxson P; Blyler CA; Lynch K; Cohen LP; Tajeu GS; Fontil V; Moy NB; Ebinger JE; Rader F; Bibbins-Domingo K; Bellows BK
    Circulation; 2021 Jun; 143(24):2384-2394. PubMed ID: 33855861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Efficiency of the Barbershop Model of Hypertension Care for Black Men With Virtual Visits.
    Blyler CA; Ebinger J; Rashid M; Moy NP; Cheng S; Albert CM; Rader F
    J Am Heart Assoc; 2021 Jul; 10(13):e020796. PubMed ID: 34155907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability of Blood Pressure Reduction in Black Barbershops.
    Victor RG; Blyler CA; Li N; Lynch K; Moy NB; Rashid M; Chang LC; Handler J; Brettler J; Rader F; Elashoff RM
    Circulation; 2019 Jan; 139(1):10-19. PubMed ID: 30592662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.
    Victor RG; Lynch K; Li N; Blyler C; Muhammad E; Handler J; Brettler J; Rashid M; Hsu B; Foxx-Drew D; Moy N; Reid AE; Elashoff RM
    N Engl J Med; 2018 Apr; 378(14):1291-1301. PubMed ID: 29527973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
    Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
    PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustainability of blood pressure reduction in black barbershops.
    Blyler CA; Rader F
    Curr Opin Cardiol; 2019 Nov; 34(6):693-699. PubMed ID: 31425171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value.
    Kazi DS; Wei PC; Penko J; Bellows BK; Coxson P; Bryant KB; Fontil V; Blyler CA; Lyles C; Lynch K; Ebinger J; Zhang Y; Tajeu GS; Boylan R; Pletcher MJ; Rader F; Moran AE; Bibbins-Domingo K
    Circulation; 2021 Jun; 143(24):2406-2408. PubMed ID: 34125566
    [No Abstract]   [Full Text] [Related]  

  • 8. It's Time for a Haircut: a Perspective on Barbershop Health Interventions Serving Black Men.
    Bryant KB; Blyler CA; Fullilove RE
    J Gen Intern Med; 2020 Oct; 35(10):3057-3059. PubMed ID: 32180133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative analysis of post-hoc interviews with multilevel participants of a randomized controlled trial of a community-based intervention.
    Kohrman N; Rashid M; Flores R; Blyler C; Barragan NC; Kuo T; Inkelas M; Chen S; Rader F; Cheng S; Albert C; Bello NA; Ebinger J
    PLoS One; 2024; 19(5):e0303075. PubMed ID: 38723012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension.
    Liao CT; Toh HS; Sun L; Yang CT; Hu A; Wei D; Melgarejo J; Zhang ZY
    JAMA Netw Open; 2023 Feb; 6(2):e230708. PubMed ID: 36848091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.
    Bress AP; Bellows BK; King JB; Hess R; Beddhu S; Zhang Z; Berlowitz DR; Conroy MB; Fine L; Oparil S; Morisky DE; Kazis LE; Ruiz-Negrón N; Powell J; Tamariz L; Whittle J; Wright JT; Supiano MA; Cheung AK; Weintraub WS; Moran AE;
    N Engl J Med; 2017 Aug; 377(8):745-755. PubMed ID: 28834469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Intensive Blood Pressure Management.
    Richman IB; Fairley M; Jørgensen ME; Schuler A; Owens DK; Goldhaber-Fiebert JD
    JAMA Cardiol; 2016 Nov; 1(8):872-879. PubMed ID: 27627731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management.
    Schultz BG; Tilton J; Jun J; Scott-Horton T; Quach D; Touchette DR
    Value Health; 2021 Apr; 24(4):522-529. PubMed ID: 33840430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
    Jönsson B; Carides GW; Burke TA; Dasbach EJ; Lindholm LH; Dahlöf B;
    J Hypertens; 2005 Jul; 23(7):1425-31. PubMed ID: 15942467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
    Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
    Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.
    Shireman TI; Svarstad BL
    J Am Pharm Assoc (2003); 2016; 56(4):389-96. PubMed ID: 27184784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?
    Cadilhac DA; Carter R; Thrift AG; Dewey HM
    Stroke; 2012 May; 43(5):1370-5. PubMed ID: 22363058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.